Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ovarian Clear Cell Carcinoma”

170 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 170 results

Not applicableUnknownNCT05600998
What this trial is testing

Camrelizumab in Combination With Anlotinib in Subjects Advanced Ovarian Clear Cell Carcinoma

Who this might be right for
Ovarian Clear Cell Carcinoma
Peking University Third Hospital 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05032040
What this trial is testing

XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies

Who this might be right for
Ovarian CancerClear Cell CarcinomaEndometrial Cancer+2 more
Xencor, Inc. 170
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 798
Not applicableStudy completedNCT02129036
What this trial is testing

Ovarian Clear Cell Adenocarcinoma Review

Who this might be right for
Ovarian Cysts
Cathay General Hospital 5
Large-scale testing (Phase 3)Active Not RecruitingNCT01167712
What this trial is testing

Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube Endometrioid AdenocarcinomaFallopian Tube Mucinous AdenocarcinomaFallopian Tube Transitional Cell Carcinoma+27 more
National Cancer Institute (NCI) 692
Early research (Phase 1)Study completedNCT00079430
What this trial is testing

Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Brenner TumorFallopian Tube CancerOvarian Clear Cell Cystadenocarcinoma+9 more
National Cancer Institute (NCI) 113
Early research (Phase 1)Study completedNCT00005026
What this trial is testing

Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerPrimary Peritoneal Cavity Cancer
Gynecologic Oncology Group
Early research (Phase 1)Study completedNCT00006235
What this trial is testing

Liposomal Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Gynecologic Oncology Group
Testing effectiveness (Phase 2)Ended earlyNCT00788125
What this trial is testing

Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+8 more
City of Hope Medical Center 7
Not applicableUnknownNCT00238342
What this trial is testing

Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass

Who this might be right for
Fallopian Tube CancerOvarian Cancer
Gynecologic Oncology Group 2,000
Testing effectiveness (Phase 2)UnknownNCT03405454
What this trial is testing

A Multicentre Phase II Trial of Durvalumab Versus Physician's Choice Chemotherapy in Recurrent Ovarian Clear Cell Adenocarcinomas

Who this might be right for
Ovarian Clear Cell Carcinoma
National University Hospital, Singapore 46
Early research (Phase 1)Study completedNCT00101972
What this trial is testing

RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma

Who this might be right for
Cancer
MacroGenics 53
Early research (Phase 1)Study completedNCT00066651
What this trial is testing

Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors

Who this might be right for
Cervical CancerFallopian Tube CancerHead and Neck Cancer+5 more
National Cancer Institute (NCI)
Early research (Phase 1)Ended earlyNCT03924245
What this trial is testing

Olaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal, Fallopian Tube Cancers

Who this might be right for
Fallopian Tube CancerFallopian Tube CarcinosarcomaFallopian Tube Clear Cell Adenocarcinoma+10 more
Vanderbilt-Ingram Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT00217529
What this trial is testing

Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03602586
What this trial is testing

Testing Whether the Combination of Two Immunotherapy Drugs Have Activity in Recurrent or Persistent Clear Cell Ovarian Cancer

Who this might be right for
Malignant Ovarian Clear Cell TumorRecurrent Ovarian Carcinoma
National Cancer Institute (NCI) 14
Not applicableEnded earlyNCT01275664
What this trial is testing

Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer

Who this might be right for
Nausea and VomitingOvarian Brenner TumorOvarian Clear Cell Cystadenocarcinoma+24 more
Gynecologic Oncology Group 4
Not applicableLooking for participantsNCT06279104
What this trial is testing

A Comparative Study of the Treatment of Real-world Patients With Clear Cell Carcinoma of the Ovary

Who this might be right for
Ovarian Clear Cell Carcinoma
Tongji Hospital 150
Testing effectiveness (Phase 2)Study completedNCT00888615
What this trial is testing

Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid AdenocarcinomaFallopian Tube Mucinous Adenocarcinoma+15 more
GOG Foundation 58
Not applicableEnded earlyNCT00899093
What this trial is testing

YKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Receiving Chemotherapy

Who this might be right for
Fallopian Tube AdenocarcinomaFallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid Adenocarcinoma+27 more
Gynecologic Oncology Group 2,500
Load More Results